Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Current Assets (2016 - 2025)

Historic Current Assets for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to $99.5 million.

  • vTv Therapeutics' Current Assets rose 13151.92% to $99.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.5 million, marking a year-over-year increase of 13151.92%. This contributed to the annual value of $38.1 million for FY2024, which is 25763.35% up from last year.
  • vTv Therapeutics' Current Assets amounted to $99.5 million in Q3 2025, which was up 13151.92% from $26.4 million recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Current Assets ranged from a high of $99.5 million in Q3 2025 and a low of $9.2 million during Q1 2021
  • For the 5-year period, vTv Therapeutics' Current Assets averaged around $29.1 million, with its median value being $26.4 million (2025).
  • As far as peak fluctuations go, vTv Therapeutics' Current Assets soared by 50280.04% in 2021, and later tumbled by 6482.3% in 2023.
  • vTv Therapeutics' Current Assets (Quarter) stood at $15.6 million in 2021, then surged by 73.45% to $27.1 million in 2022, then tumbled by 60.67% to $10.7 million in 2023, then surged by 257.63% to $38.1 million in 2024, then soared by 160.95% to $99.5 million in 2025.
  • Its Current Assets stands at $99.5 million for Q3 2025, versus $26.4 million for Q2 2025 and $31.9 million for Q1 2025.